Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05537766
Title Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (ZUMA-25)
Acronym ZUMA-25
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kite, A Gilead Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | FRA | ESP | DEU | CHE | AUT


No variant requirements are available.